ERAXIS

Product Overview

About ERAXIS

ERAXIS is a medicine that contains the active ingredient ANIDULAFUNGIN, which is used to treat certain serious fungal infections. It belongs to a class of drugs known as echinocandins, which work by interfering with the formation of the fungal cell wall, ultimately leading to the death of the fungal cells. ERAXIS is specifically designed to target and eliminate Candida fungi, which can cause severe and potentially life-threatening infections in individuals with weakened immune systems.

Key Benefits & Uses

• Treatment of candidemia, which is a fungal infection of the blood
• Treatment of other Candida infections, such as intra-abdominal abscesses and peritonitis
• Treatment of esophageal candidiasis, which is a fungal infection of the esophagus

Active Ingredient & Action

ANIDULAFUNGIN, the active ingredient in ERAXIS, works by inhibiting the synthesis of beta-1,3-D-glucan, an essential component of the fungal cell wall. This inhibition leads to cell lysis and death, effectively clearing the fungal infection from the body. The mechanism of action of ANIDULAFUNGIN is highly specific, reducing the risk of resistance and making ERAXIS a valuable treatment option for patients with severe fungal infections.

Important Notes

ERAXIS should only be used under the guidance of a healthcare professional, as it is a prescription-only medicine. Patients should follow the recommended dosage and administration instructions carefully, and report any adverse reactions or concerns to their doctor. It is also important to note that ERAXIS is not indicated for the treatment of fungal infections caused by non-Candida species, and its use in patients with certain underlying medical conditions may require careful monitoring and dose adjustment.